• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011

tetano

Editor, Senior Moderator
J Microbiol. 2012 Dec;50(6):1067-70. doi: 10.1007/s12275-012-2541-3. Epub 2012 Dec 30.
Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011.
Park S, Kim JI, Lee I, Lee S, Hwang MW, Bae JY, Heo J, Lim EJ, Seok WS, Cheong HJ, Song JY, Kim WJ, Park MS.
Source

Department of Microbiology, Hallym University, Chuncheon, 200-702, Republic of Korea.
Abstract

During the 2009-2011 influenza seasons, 10.26% of the specimens isolated from patients in South Korea were subtyped as H3N2 viruses. Some oseltamivir-sensitive H3N2 samples exhibited different plaque morphologies, and were found to have novel mutations in the neuraminidase gene. In a subsequent analysis using NA mutant viruses, viral compensation against oseltamivir treatment was observed only in the N2 mutant virus. All things considered, these novel mutations may account for the exclusive characteristics of selected H3N2 viruses observed in plaque reduction assays.

PMID:
23274998
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23274998
 
Back
Top Bottom